Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 6, 2024
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.
The Journal of Investigative Dermatology|May 13, 2011
Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinomaDavid Schrama, Wiebke K Peitsch, Marc Zapatka, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREGValerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Deep neural networks are superior to dermatologists in melanoma image classificationTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2019
Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmarkTitus J Brinker, Achim Hekler, Axel Hauschild, et al.
Cancers|July 2, 2021
Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In VivoBarbara Schwertner, Georg Lindner, Camila Toledo Stauner, et al.
Oncoimmunology|September 18, 2018
Evolution of melanoma cross-resistance to CD8Natalia Pieper, Anne Zaremba, Sonia Leonardelli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2019
Superior skin cancer classification by the combination of human and artificial intelligenceAchim Hekler, Jochen S Utikal, Alexander H Enk, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
International Journal of Cancer|March 15, 2026
Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO studyRalf Gutzmer, Michael Weichenthal, Thomas Eigentler, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|January 6, 2024
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.
The Journal of Investigative Dermatology|May 13, 2011
Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinomaDavid Schrama, Wiebke K Peitsch, Marc Zapatka, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREGValerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Deep neural networks are superior to dermatologists in melanoma image classificationTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2019
Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmarkTitus J Brinker, Achim Hekler, Axel Hauschild, et al.
Cancers|July 2, 2021
Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In VivoBarbara Schwertner, Georg Lindner, Camila Toledo Stauner, et al.
Oncoimmunology|September 18, 2018
Evolution of melanoma cross-resistance to CD8Natalia Pieper, Anne Zaremba, Sonia Leonardelli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2019
Superior skin cancer classification by the combination of human and artificial intelligenceAchim Hekler, Jochen S Utikal, Alexander H Enk, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
International Journal of Cancer|March 15, 2026
Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO studyRalf Gutzmer, Michael Weichenthal, Thomas Eigentler, et al.
Pageof 15